Results 161 to 170 of about 16,696 (211)

Oncolytic Properties of the Chimeric Poxvirus HOV-2 in Cholangiocarcinoma Models. [PDF]

open access: yesJ Am Coll Surg
Chen C   +9 more
europepmc   +1 more source

The Evolution of Poxvirus Vaccines [PDF]

open access: yesViruses, 2015
After Edward Jenner established human vaccination over 200 years ago, attenuated poxviruses became key players to contain the deadliest virus of its own family: Variola virus (VARV), the causative agent of smallpox. Cowpox virus (CPXV) and horsepox virus (HSPV) were extensively used to this end, passaged in cattle and humans until the appearance of ...
Beatriz Perdiguero   +2 more
exaly   +5 more sources

Poxvirus tropism [PDF]

open access: yesNature Reviews Microbiology, 2005
Despite the success of the WHO-led smallpox eradication programme a quarter of a century ago, there remains considerable fear that variola virus, or other related pathogenic poxviruses such as monkeypox, could re-emerge and spread disease in the human population.
Diana Thomas
exaly   +3 more sources
Some of the next articles are maybe not open access.

Related searches:

Ribosomes in poxvirus infection

Current Opinion in Virology, 2022
Poxviruses are large double-stranded DNA viruses that encode their own DNA replication, transcription, and mRNA biogenesis machinery, which underlies their ability to replicate entirely in the cytoplasm. However, like all other viruses, poxviruses remain dependent on host ribosomes to translate their mRNAs into the viral proteins needed to complete ...
Chorong, Park, Derek, Walsh
openaire   +2 more sources

Poxvirus Exploitation of the Ubiquitin-Proteasome System

open access: yesViruses, 2010
Ubiquitination plays a critical role in many cellular processes. A growing number of viruses have evolved strategies to exploit the ubiquitin-proteasome system, including members of the Poxviridae family. Members of the poxvirus family have recently been
Nicholas van Buuren, Michele Barry
exaly   +2 more sources

The Poxvirus Antigens

1969
Only a short time has elapsed since the poxvirus literature was reviewed in a most thorough and comprehensive fashion (Joklik, 1966). It is the purpose of this communication to focus in somewhat more detail on a single facet of the overall picture, the poxvirus-coded proteins or antigens.
W C, Wilcox, G H, Cohen
openaire   +2 more sources

Poxvirus oncolytic virotherapy

Expert Opinion on Biological Therapy, 2019
Over the last decade, advances in biological therapies have resulted in remarkable clinical responses for the treatment of some previously incurable cancers. Oncolytic virotherapy is one of these promising novel strategies for cancer therapy. A successful oncolytic virus promotes tumor cell oncolysis and elicits a robust long-term anti-tumor immunity ...
Lino E, Torres-Domínguez   +1 more
openaire   +2 more sources

Poxvirus Cancer Therapy

Recent Patents on Anti-Infective Drug Discovery, 2006
Despite many advances in chemotherapy and other medical techniques, patients with cancer often develop local recurrence or metastatic spread. Recent advances in molecular biology and tumor immunology have led to the design of many new anti-tumor vaccines. Such approaches are now using recombinant viruses to treat different types of cancer.
Philippe-Alexandre, Gilbert   +1 more
openaire   +2 more sources

POXVIRUS INFECTION AND APOPTOSIS

International Reviews of Immunology, 2004
The following excellent reviews have been published on poxviruses and apoptosis during the last few years: P.C. Turner and R.W. Moyer, Semin. Virology, 8: 453-469, 1998; J.L. Shisler and B. Moss, Semin. Immunol., 13: 67-72, 2001; and H. Everett and G. McFadden, Curr. Opin. Microbiol., 5: 395-402, 2002.
Beatriz G-T, Pogo   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy